Exome Asset Management LLC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 2011932
NEW YORK, NY
Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,318,183
+$365,672 QoQ
Shares Held
137,115
-23.6% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
2.05%
of 13F equity value
Holder Rank
#66
of 193 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Exome Asset Management LLC holds $110,788,985 across 37 Biotechnology names. GLUE ranks #13 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
27,205 | $9,107,961 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
164,915 | $9,060,430 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
210,523 | $8,147,240 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
88,177 | $6,991,554 | |
| 5 | ABVX |
Abivax S.A.
|
46,878 | $6,246,962 | |
| 6 | ALMS |
Alumis Inc.
|
204,418 | $5,752,322 | |
| 7 | CYTK |
Cytokinetics Inc
|
60,056 | $5,116,170 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
100,203 | $5,085,302 |
All Filings in GLUE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,318,183 | 137,115 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,952,511 | 179,484 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||